Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery

Andreas H. Laustsen*, Victor Greiff, Aneesh Karatt-Vellatt, Serge Muyldermans, Timothy P. Jenkins

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


For years, a discussion has persevered on the benefits and drawbacks of antibody discovery using animal immunization versus in vitro selection from non-animal-derived recombinant repertoires using display technologies. While it has been argued that using recombinant display libraries can reduce animal consumption, we hold that the number of animals used in immunization campaigns is dwarfed by the number sacrificed during preclinical studies. Thus, improving quality control of antibodies before entering in vivo studies will have a larger impact on animal consumption. Both animal immunization and recombinant repertoires present unique advantages for discovering antibodies that are fit for purpose. Furthermore, we anticipate that machine learning will play a significant role within discovery workflows, refining current antibody discovery practices.
Original languageEnglish
JournalTrends in Biotechnology
Number of pages11
Publication statusAccepted/In press - 2021

Fingerprint Dive into the research topics of 'Animal Immunization, <i>in Vitro</i> Display Technologies, and Machine Learning for Antibody Discovery'. Together they form a unique fingerprint.

Cite this